News

The Government of Canada has taken initiatives to support healthcare professionals in treating and preventing H1N1 flu virus infections in Canada. The government has taken two initiatives. Accordingly,

CellaVision is adapting its current range of products for use in veterinary laboratories. Several veterinary laboratories are evaluating CellaVision’s products in Sweden and the US. The results are

Gen-Probe has initiated a clinical trial intended to secure US regulatory approval of its PROGENSA PCA3 assay, a new molecular test that may help to determine the need

Neuland Laboratories (Neuland) has initiated manufacturing of peptides blocks by commercializing the production of Fmoc Pseudoproline Dipeptides and other building blocks in India and the US subsidiary. The

Warnex has reported that its Medical Laboratories division has launched a test for the detection of a mutation of the pandemic influenza A H1N1 virus, which is associated

NewCardio has reported that three contract research organizations (CROs) have signed a Master Services Agreement (MSA), to use NewCardio’s Qtinno software suite as its technology in fully automated

Synygy and Daiichi Sankyo (DSI) has extended their 12-year relationship with Synygy for another five years with a new agreement for SPM software, sales compensation plan management outsourcing

SourceSolution has entered into a co-marketing agreement with bioProcessUK. The agreement consists of several provisions including co-promotion of each organisation’s products and offerings. The co-marketing efforts are expected

A comparative effectiveness study performed by HealthCore published by Mayo Clinic has showed that asthma patients in general had better clinical outcomes with oral controllers than inhaled corticosteroids.